Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV

We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijekoon, Lanka, Sarathchandra, Chamara, Siribaddana, Sisira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937680/
https://www.ncbi.nlm.nih.gov/pubmed/36819409
http://dx.doi.org/10.7759/cureus.33952
_version_ 1784890476717932544
author Wijekoon, Lanka
Sarathchandra, Chamara
Siribaddana, Sisira
author_facet Wijekoon, Lanka
Sarathchandra, Chamara
Siribaddana, Sisira
author_sort Wijekoon, Lanka
collection PubMed
description We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first BBIBP-CorV vaccine. A bifacial palsy with a paresthesia variant of GBS was diagnosed, and the patient was treated with intravenous immunoglobulin, arresting the progression of neurological symptoms. Clinicians need to be aware of the possibility of GBS following vaccination with BBIBP-CorV, an inactivated SARS-CoV-2 vaccine.
format Online
Article
Text
id pubmed-9937680
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99376802023-02-18 Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV Wijekoon, Lanka Sarathchandra, Chamara Siribaddana, Sisira Cureus Neurology We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first BBIBP-CorV vaccine. A bifacial palsy with a paresthesia variant of GBS was diagnosed, and the patient was treated with intravenous immunoglobulin, arresting the progression of neurological symptoms. Clinicians need to be aware of the possibility of GBS following vaccination with BBIBP-CorV, an inactivated SARS-CoV-2 vaccine. Cureus 2023-01-18 /pmc/articles/PMC9937680/ /pubmed/36819409 http://dx.doi.org/10.7759/cureus.33952 Text en Copyright © 2023, Wijekoon et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Wijekoon, Lanka
Sarathchandra, Chamara
Siribaddana, Sisira
Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title_full Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title_fullStr Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title_full_unstemmed Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title_short Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
title_sort guillain-barré syndrome following the first dose of inactivated sars-cov-2 vaccine, bbibp-corv
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937680/
https://www.ncbi.nlm.nih.gov/pubmed/36819409
http://dx.doi.org/10.7759/cureus.33952
work_keys_str_mv AT wijekoonlanka guillainbarresyndromefollowingthefirstdoseofinactivatedsarscov2vaccinebbibpcorv
AT sarathchandrachamara guillainbarresyndromefollowingthefirstdoseofinactivatedsarscov2vaccinebbibpcorv
AT siribaddanasisira guillainbarresyndromefollowingthefirstdoseofinactivatedsarscov2vaccinebbibpcorv

Ejemplares similares